Explore India's leading biotech companies driving innovation in healthcare and beyond.

Top Biotech Stocks in India by Market Capitalization

India's biotech industry, fueled by initiatives like "Make in India," spans biopharmaceuticals, bio-agriculture, and bioinformatics, with a market value expected to surpass $150 billion by 2025.

Overview of the Biotech Industry in India

Biocon Ltd., headquartered in Bangalore, specializes in biopharmaceuticals, biosimilars, and research-driven therapies for diabetes and oncology. Market Cap: ₹44,001.99 Crore (as of Dec 31, 2024). Source: NSE.

Biocon Ltd.

Concord Biotech Ltd. (Market Cap: ₹23,538.65 Cr) specializes in fermentation-based biopharmaceuticals, providing APIs for immunosuppressants and oncology. Based in Ahmedabad. Data as of 31st Dec 2024. NSE.

Concord Biotech Ltd.

Sun Pharma Advanced Research (Market Cap: ₹6,487.19 Cr), based in Mumbai, focuses on new chemical entities and innovative drug delivery systems to enhance therapeutic efficacy. Data as of 31st Dec 2024. Source: NSE.

Sun Pharma Advanced Research Co.

Windlas Biotech Ltd. (Market Cap: ₹2,152.73 Cr), based in Dehradun, specializes in contract development and manufacturing, supporting global pharma brands with high-quality formulations. Data as of 31st Dec 2024. Source: NSE.

Windlas Biotech Ltd.

Market Cap: ₹55.11 Crore Based in Hyderabad, Vivo Biotech is a leader in preclinical contract research and biologics development, catering to global pharmaceutical companies. Data as of 31st December 2024. Source - NSE

ANG Lifesciences Ltd.

Vivo Biotech Ltd. (Market Cap: ₹55.11 Cr), based in Hyderabad, is a leader in preclinical contract research and biologics development, serving global pharmaceutical companies. Data as of 31st Dec 2024. Source: NSE.

Vivo Biotech Ltd.

Summary India's biotech sector is thriving, fueled by innovation, R&D, and supportive policies. Companies like Biocon, Concord Biotech, and Windlas Biotech are leading this charge with groundbreaking contributions. Data as of 31st December 2024. Source NSE

Summary

-->